Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


06.08.2018

1 Arch Gynecol Obstet
2 Asian Pac J Cancer Prev
1 BMC Womens Health
1 Brachytherapy
1 Carcinogenesis
1 Case Rep Surg
2 Crit Rev Biomed Eng
1 Curr Probl Cancer
1 Eur J Obstet Gynecol Reprod Biol
1 Eur Radiol
1 Eur Rev Med Pharmacol Sci
1 Front Genet
1 Front Immunol
1 Gynecol Oncol
1 Int J Biol Macromol
1 Int J Gynecol Pathol
1 Int J Oncol
1 J Appl Clin Med Phys
1 J Cancer Res Clin Oncol
1 J Drug Target
3 J Gynecol Oncol
1 J Health Commun
2 J Low Genit Tract Dis
1 J Minim Invasive Gynecol
1 J Pathol Clin Res
1 J Radiat Res
1 JAMA Oncol
1 Mater Sociomed
1 Onco Targets Ther
2 Pathology
1 PeerJ
1 Proc Natl Acad Sci U S A
1 Sci Rep
1 Tumour Biol
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Gynecol Obstet

  1. DASKALAKIS G, Diamantopoulos D, Theodora M, Semertzidou A, et al
    3D vocal power Doppler sonography for the estimation of tumor volume and vascularization in stage IB1 cervical cancer.
    Arch Gynecol Obstet. 2018 Jul 28. pii: 10.1007/s00404-018-4842.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  2. DAS A, K H, S K DK, K HR, et al
    Evaluation of Therapeutic Potential of Eugenol-A Natural Derivative of Syzygium aromaticum on Cervical Cancer
    Asian Pac J Cancer Prev. 2018;19:1977-1985.
    PubMed     Text format     Abstract available

  3. MRUTS KB, Gebremariam TB
    Knowledge and Perception Towards Cervical Cancer among Female Debre Berhan University Students
    Asian Pac J Cancer Prev. 2018;19:1771-1777.
    PubMed     Text format     Abstract available


    BMC Womens Health

  4. KANEKO N
    Factors associated with cervical cancer screening among young unmarried Japanese women: results from an internet-based survey.
    BMC Womens Health. 2018;18:132.
    PubMed     Text format     Abstract available


    Brachytherapy

  5. ANNEDE P, Mailleux H, Sfumato P, Ferre M, et al
    Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer.
    Brachytherapy. 2018 Jul 27. pii: S1538-4721(18)30101.
    PubMed     Text format     Abstract available


    Carcinogenesis

  6. GAO J, Yang Y, Qiu R, Zhang K, et al
    Proteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancer.
    Carcinogenesis. 2018 Jul 23. pii: 5057053. doi: 10.1093.
    PubMed     Text format     Abstract available


    Case Rep Surg

  7. KAMEI Y, Miyoshi A, Wakui N, Hara T, et al
    Successful Pregnancy following Myomectomy Accompanied with Abdominal Radical Trachelectomy for an Infertile Woman with Early Cervical Cancer: A Case Report and Literature Review.
    Case Rep Surg. 2018;2018:5623717.
    PubMed     Text format     Abstract available


    Crit Rev Biomed Eng

  8. KUDVA V, Prasad K, Guruvare S
    Automation of Detection of Cervical Cancer Using Convolutional Neural Networks.
    Crit Rev Biomed Eng. 2018;46:135-145.
    PubMed     Text format     Abstract available

  9. KUDVA V, Prasad K
    Pattern Classification of Images from Acetic Acid-Based Cervical Cancer Screening: A Review.
    Crit Rev Biomed Eng. 2018;46:117-133.
    PubMed     Text format     Abstract available


    Curr Probl Cancer

  10. VU M, Yu J, Awolude OA, Chuang L, et al
    Cervical cancer worldwide.
    Curr Probl Cancer. 2018 Jun 25. pii: S0147-0272(18)30134.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  11. VILORIA ME, Bravo J, Carrero Y, Mosquera JA, et al
    In situ expressions of protein 16 (p16(CDKN2A)) and transforming growth factor beta-1 in patients with cervical intraepithelial neoplasia and cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2018;228:303-307.
    PubMed     Text format     Abstract available


    Eur Radiol

  12. LIN G, Yang LY, Lin YC, Huang YT, et al
    Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Eur Radiol. 2018 Jul 26. pii: 10.1007/s00330-018-5651.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  13. CHU XY, Li ZJ, Zheng ZW, Tao YL, et al
    KEAP1/NRF2 signaling pathway mutations in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2018;22:4458-4466.
    PubMed     Text format     Abstract available


    Front Genet

  14. WANG XB, Cui NH, Liu XN, Ma JF, et al
    Identification of DAPK1 Promoter Hypermethylation as a Biomarker for Intra-Epithelial Lesion and Cervical Cancer: A Meta-Analysis of Published Studies, TCGA, and GEO Datasets.
    Front Genet. 2018;9:258.
    PubMed     Text format     Abstract available


    Front Immunol

  15. HEEREN AM, van Dijk I, Berry DRAI, Khelil M, et al
    Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer.
    Front Immunol. 2018;9:1598.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  16. MATSUO K, Blake EA, Machida H, Mandelbaum RS, et al
    Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
    Gynecol Oncol. 2018 Jul 24. pii: S0090-8258(18)31080.
    PubMed     Text format     Abstract available


    Int J Biol Macromol

  17. QIU J, Zhang H, Wang Z, Liu D, et al
    The antitumor effect of folic acid conjugated-Auricularia auricular polysaccharide-cisplatin complex on cervical carcinoma cells in nude mice.
    Int J Biol Macromol. 2018;107.
    PubMed     Text format     Abstract available


    Int J Gynecol Pathol

  18. TOKINAGA-UCHIYAMA A, Mizushima T, Akimoto K, Nagashima Y, et al
    Aberrant Nuclear Localization of aPKClambda/iota is Associated With Poorer Prognosis in Uterine Cervical Cancer.
    Int J Gynecol Pathol. 2018 Jul 27. doi: 10.1097/PGP.0000000000000539.
    PubMed     Text format     Abstract available


    Int J Oncol

  19. LV Q, Wu K, Liu F, Wu W, et al
    Interleukin17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer.
    Int J Oncol. 2018 Jul 26. doi: 10.3892/ijo.2018.4503.
    PubMed     Text format     Abstract available


    J Appl Clin Med Phys

  20. WANG Y, Chen L, Zhu F, Guo W, et al
    A study of minimum segment width parameter on VMAT plan quality, delivery accuracy, and efficiency for cervical cancer using Monaco TPS.
    J Appl Clin Med Phys. 2018 Jul 30. doi: 10.1002/acm2.12422.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  21. HEUBLEIN S, Friese K, Kost B, Marme F, et al
    TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.
    J Cancer Res Clin Oncol. 2018 Jul 30. pii: 10.1007/s00432-018-2706.
    PubMed     Text format     Abstract available


    J Drug Target

  22. DU H, Chen Y
    Competing endogenous RNA networks in cervical cancer: function, mechanism, and perspective.
    J Drug Target. 2018 Jul 27:1-47. doi: 10.1080/1061186X.2018.1505894.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  23. COOREVITS L, Traen A, Binge L, Van Dorpe J, et al
    Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
    J Gynecol Oncol. 2018;29:e8.
    PubMed     Text format     Abstract available

  24. CHANG CC, Wang HC, Liao YP, Chen YC, et al
    The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
    J Gynecol Oncol. 2018;29:e17.
    PubMed     Text format     Abstract available

  25. OUH YT, Min KJ, Cho HW, Ki M, et al
    Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    J Gynecol Oncol. 2018;29:e14.
    PubMed     Text format     Abstract available


    J Health Commun

  26. CHEN NN, Moran MB, Frank LB, Ball-Rokeach SJ, et al
    Understanding Cervical Cancer Screening among Latinas through the Lens of Structure, Culture, Psychology and Communication.
    J Health Commun. 2018 Jul 30:1-9. doi: 10.1080/10810730.2018.1500661.
    PubMed     Text format     Abstract available


    J Low Genit Tract Dis

  27. POWELL TC, Dilley SE, Bae S, Straughn JM Jr, et al
    The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical Cancer.
    J Low Genit Tract Dis. 2018 Jul 30. doi: 10.1097/LGT.0000000000000421.
    PubMed     Text format     Abstract available

  28. ENDESHAW M, Clarke T, Senkomago V, Saraiya M, et al
    Cervical Cancer Screening Among Women by Birthplace and Percent of Lifetime Living in the United States.
    J Low Genit Tract Dis. 2018 Jul 30. doi: 10.1097/LGT.0000000000000422.
    PubMed     Text format     Abstract available


    J Minim Invasive Gynecol

  29. BOYRAZ G, Karalok A, Basaran D, Turan T, et al
    Vaginal Closure with EndoGIA to Prevent Tumor Spillage in Laparoscopic Radical Hysterectomy for Cervical Cancer.
    J Minim Invasive Gynecol. 2018 Jul 28. pii: S1553-4650(18)30363.
    PubMed     Text format     Abstract available


    J Pathol Clin Res

  30. GARLAND SM, Dimech W, Collignon P, Cooley L, et al
    The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality.
    J Pathol Clin Res. 2018 Jul 30. doi: 10.1002.
    PubMed     Text format     Abstract available


    J Radiat Res

  31. TAMAKI T, Hirai R, Igari M, Kumazaki Y, et al
    Dosimetric comparison of three-dimensional conformal radiotherapy versus volumetric-arc radiotherapy in cervical cancer treatment: applying the central-shielding principle to modern technology.
    J Radiat Res. 2018 Jul 21. pii: 5056948. doi: 10.1093.
    PubMed     Text format     Abstract available


    JAMA Oncol

  32. WANG Y, Farmer M, Izaguirre EW, Schwartz DL, et al
    Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer.
    JAMA Oncol. 2018 Jul 26. pii: 2688513. doi: 10.1001/jamaoncol.2018.2677.
    PubMed     Text format    


    Mater Sociomed

  33. LUKAC A, Sulovic N, Smiljic S, Ilic AN, et al
    The Prevalence of the Most Important Risk Factors Associated with Cervical Cancer.
    Mater Sociomed. 2018;30:131-135.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  34. ZHU L, Zheng X, Du Y, Xing Y, et al
    Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer.
    Onco Targets Ther. 2018;11:4207-4220.
    PubMed     Text format     Abstract available


    Pathology

  35. ONDIC O, Alaghehbandan R
    Response to: High-grade squamous intraepithelial lesion (HSIL) of the cervix with bizarre cytological appearances ('pleomorphic HSIL').
    Pathology. 2018;50:369-370.
    PubMed     Text format    

  36. STEWART CJR
    Response to: High-grade squamous intraepithelial lesion (HSIL) of the cervix with bizarre cytological appearances ('pleomorphic HSIL'): author reply.
    Pathology. 2018;50:370.
    PubMed     Text format    


    PeerJ

  37. TAN MS, Chang SW, Cheah PL, Yap HJ, et al
    Integrative machine learning analysis of multiple gene expression profiles in cervical cancer.
    PeerJ. 2018;6:e5285.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  38. XIANG S, Gu H, Jin L, Thorne RF, et al
    LncRNA IDH1-AS1 links the functions of c-Myc and HIF1alpha via IDH1 to regulate the Warburg effect.
    Proc Natl Acad Sci U S A. 2018;115:E1465-E1474.
    PubMed     Text format     Abstract available


    Sci Rep

  39. MENG J, Liu S, Zhu L, Zhu L, et al
    Texture Analysis as Imaging Biomarker for recurrence in advanced cervical cancer treated with CCRT.
    Sci Rep. 2018;8:11399.
    PubMed     Text format     Abstract available


    Tumour Biol

  40. ZAJKOWSKA M, Zbucka-Kretowska M, Sidorkiewicz I, Lubowicka E, et al
    Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
    Tumour Biol. 2018;40:1010428318790363.
    PubMed     Text format     Abstract available


    Vaccine

  41. RIESEN M, Garcia V, Low N, Althaus CL, et al
    Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31532.
    PubMed     Text format     Abstract available

  42. LAWTON B, Howe AS, Turner N, Filoche S, et al
    Association of prior HPV vaccination with reduced preterm birth: A population based study.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31579.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: